OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
-1.06%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.28%
AUM
$471M
AUM Growth
+$471M
(-12%)
Cap. Flow
-$18.7M
Cap. Flow
% of AUM
-3.96%
Top 10 Holdings %
Top 10 Hldgs %
58.75%
Holding
54
New
6
Increased
11
Reduced
10
Closed
15
Top Buys
| 1 |
Crinetics Pharmaceuticals
CRNX
|
$9.16M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$8.7M |
| 3 |
Ginkgo Bioworks
DNA
|
$7.73M |
| 4 |
Merus
MRUS
|
$6.92M |
| 5 |
Hyperfine
HYPR
|
$5.52M |
Top Sells
| 1 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$7.17M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$6.98M |
| 3 |
Celldex Therapeutics
CLDX
|
$5.45M |
| 4 |
AFIB
Acutus Medical, Inc. Common Stock
AFIB
|
$5.22M |
| 5 |
Keros Therapeutics
KROS
|
$5.08M |
Sector Composition
| 1 | Healthcare | 100% |